Your browser doesn't support javascript.
loading
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease.
Widjaja, Anissa A; Viswanathan, Sivakumar; Shekeran, Shamini G; Adami, Eleonora; Lim, Wei-Wen; Chothani, Sonia; Tan, Jessie; Goh, Joyce Wei Ting; Chen, Hui Mei; Lim, Sze Yun; Boustany-Kari, Carine M; Hawkins, Julie; Petretto, Enrico; Hübner, Norbert; Schafer, Sebastian; Coffman, Thomas M; Cook, Stuart A.
Afiliação
  • Widjaja AA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore. anissa.widjaja@duke-nus.edu.sg.
  • Viswanathan S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Shekeran SG; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Adami E; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Lim WW; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.
  • Chothani S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Tan J; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
  • Goh JWT; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Chen HM; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
  • Lim SY; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Boustany-Kari CM; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Hawkins J; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Petretto E; Boehringer Ingelheim, CardioMetabolic Disease Research, Berlin, Germany.
  • Hübner N; Boehringer Ingelheim, CardioMetabolic Disease Research, Berlin, Germany.
  • Schafer S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Coffman TM; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.
  • Cook SA; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 13347, Berlin, Germany.
Nat Commun ; 13(1): 7497, 2022 12 05.
Article em En | MEDLINE | ID: mdl-36470928
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regeneração / Interleucina-11 / Insuficiência Renal Crônica / Anticorpos Neutralizantes / Injúria Renal Aguda / Túbulos Renais / Nefrite Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regeneração / Interleucina-11 / Insuficiência Renal Crônica / Anticorpos Neutralizantes / Injúria Renal Aguda / Túbulos Renais / Nefrite Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article